← Eichor
Study identifier: NCT05958368 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

Condition: Diabetes Mellitus, Type 2 · Insulin · Fructosamine  ·  Sponsor: Pennington Biomedical Research Center

PhaseNA
Planned participants48
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.

This description comes directly from the study's public registry record.

Talk to the study team

John W Apolzan, PhD  ·  2257632827  ·  John.Apolzan@pbrc.edu

Rob Leonard  ·  2257630948  ·  doctors@pbrc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Pennington Biomedical Research CenterBaton Rouge, Louisiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05958368